The content is available as a PDF (653.8 KB).
editorial . 2020 May 22:ciaa627. doi: 10.1093/cid/ciaa627
Renin-angiotensin-aldosterone system inhibitors impact on COVID-19 mortality: What’s next for ACE2?
Ankit B Patel
1,✉, Ashish Verma
1
Ankit B Patel, MD, PhD
1
Renal Division,
Brigham and Women’s Hospital, Boston, MA, USA
Find articles by Ankit B Patel
Ashish Verma, M.B.B.S
1
Renal Division,
Brigham and Women’s Hospital, Boston, MA, USA
Find articles by Ashish Verma
1
Renal Division,
Brigham and Women’s Hospital, Boston, MA, USA
✉
Corresponding Author: Ankit B. Patel, Brigham and Women’s Hospital, 75 Francis Street, Boston, MA 02132, Email: apatel38@bwh.harvard.edu, Phone: +001-845-709-4976
Received 2020 May 18.
Keywords: COVID-19, angiotensin converting enzyme 2, angiotensin converting enzyme inhibitors, angiotensin receptor blockers, hypertension
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.
This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)
This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.
PMCID: PMC7314195 PMID: 32442259
See "Association of Renin-angiotensin-aldosterone System Inhibitors With Coronavirus Disease 2019 (COVID-19)- Related Outcomes in Korea: A Nationwide Population-based Cohort Study" in volume 71 on page 2121.
See commentary "Association of Renin-angiotensin-aldosterone System Inhibitors With Coronavirus Disease 2019 (COVID-19)- Related Outcomes in Korea: A Nationwide Population-based Cohort Study" in volume 71 on page 2121.